BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29335871)

  • 21. Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
    Duplantier AJ; Becker SL; Bohanon MJ; Borzilleri KA; Chrunyk BA; Downs JT; Hu LY; El-Kattan A; James LC; Liu S; Lu J; Maklad N; Mansour MN; Mente S; Piotrowski MA; Sakya SM; Sheehan S; Steyn SJ; Strick CA; Williams VA; Zhang L
    J Med Chem; 2009 Jun; 52(11):3576-85. PubMed ID: 19438227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual role of D-amino acid oxidase in experimental pain models.
    Sharma J; Kulshrestha R; Singh N; Jaggi AS
    Eur J Pharmacol; 2019 Jul; 855():98-102. PubMed ID: 31059710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of spinal D-amino acid oxidase to bone cancer pain.
    Huang JL; Chen XL; Guo C; Wang YX
    Amino Acids; 2012 Nov; 43(5):1905-18. PubMed ID: 22996731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yeast D-amino acid oxidase: structural basis of its catalytic properties.
    Pollegioni L; Diederichs K; Molla G; Umhau S; Welte W; Ghisla S; Pilone MS
    J Mol Biol; 2002 Nov; 324(3):535-46. PubMed ID: 12445787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.
    Rojas C; Alt J; Ator NA; Wilmoth H; Rais R; Hin N; DeVivo M; Popiolek M; Tsukamoto T; Slusher BS
    J Psychopharmacol; 2016 Sep; 30(9):887-95. PubMed ID: 27287825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of 1-benzopyran-4-one derivatives to aldose reductase: a free energy perturbation study.
    Rastelli G; Costantino L; Gamberini MC; Del Corso A; Mura U; Petrash JM; Ferrari AM; Pacchioni S
    Bioorg Med Chem; 2002 May; 10(5):1427-36. PubMed ID: 11886805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
    Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
    FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
    Hopkins SC; Heffernan ML; Saraswat LD; Bowen CA; Melnick L; Hardy LW; Orsini MA; Allen MS; Koch P; Spear KL; Foglesong RJ; Soukri M; Chytil M; Fang QK; Jones SW; Varney MA; Panatier A; Oliet SH; Pollegioni L; Piubelli L; Molla G; Nardini M; Large TH
    J Med Chem; 2013 May; 56(9):3710-24. PubMed ID: 23631755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.
    Rojas C; Alt J; Ator NA; Thomas AG; Wu Y; Hin N; Wozniak K; Ferraris D; Rais R; Tsukamoto T; Slusher BS
    Neuropsychopharmacology; 2016 May; 41(6):1610-9. PubMed ID: 26471255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affinity-binding immobilization of D-amino acid oxidase on mesoporous silica by a silica-specific peptide.
    Wang M; Qi W; Xu H; Yu H; Zhang S; Shen Z
    J Ind Microbiol Biotechnol; 2019 Nov; 46(11):1461-1467. PubMed ID: 31289973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A
    Matricon P; Ranganathan A; Warnick E; Gao ZG; Rudling A; Lambertucci C; Marucci G; Ezzati A; Jaiteh M; Dal Ben D; Jacobson KA; Carlsson J
    Sci Rep; 2017 Jul; 7(1):6398. PubMed ID: 28743961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a D-amino acid oxidase reactor based on magnetic nanoparticles modified by a reactive polymer and its application in screening enzyme inhibitors.
    Mu X; Qiao J; Qi L; Liu Y; Ma H
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12979-87. PubMed ID: 24980686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal D-amino acid oxidase contributes to mechanical pain hypersensitivity induced by sleep deprivation in the rat.
    Wei H; Gong N; Huang JL; Fan H; Ma AN; Li XY; Wang YX; Pertovaara A
    Pharmacol Biochem Behav; 2013 Oct; 111():30-6. PubMed ID: 23958579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.
    Boehm HJ; Boehringer M; Bur D; Gmuender H; Huber W; Klaus W; Kostrewa D; Kuehne H; Luebbers T; Meunier-Keller N; Mueller F
    J Med Chem; 2000 Jul; 43(14):2664-74. PubMed ID: 10893304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase.
    Wu M; Zhou XJ; Konno R; Wang YX
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1042-6. PubMed ID: 17042912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning and expression in Escherichia coli of an active fused Zea mays L. D-amino acid oxidase.
    Gholizadeh A; Kohnehrouz BB
    Biochemistry (Mosc); 2009 Feb; 74(2):137-44. PubMed ID: 19267668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in binding free energies calculations: QM/MM-based free energy perturbation method for drug design.
    Rathore RS; Sumakanth M; Reddy MS; Reddanna P; Rao AA; Erion MD; Reddy MR
    Curr Pharm Des; 2013; 19(26):4674-86. PubMed ID: 23260025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.